Advertisement

Pädiatrie pp 329-334 | Cite as

Hyperammonämien

  • C. Bachmann

Zusammenfassung

Erhöhung der Ammoniakplasmakonzentration in zentraler Vene oder Arterie (nicht kapillär), über 50 umol/1 (1.–5. Tag: 150, Monat: 80–100 μmol/1)

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Bachmann C (1992) Ornithine carbamoyltransferase deficiency: findings, models and problems. J Inher Metab Dis 15: 578–591PubMedCrossRefGoogle Scholar
  2. Bachmann C (1998) Satellite Meeting on Advances in Inherited Urea Cycle Disorders. Recent results — new questions. J Inher Metab Dis 21/11:1–5CrossRefGoogle Scholar
  3. Feillet F, Leonard JV (1998) Alternative pathway therapy for urea cycle disorders. J Inher Metab Dis 21/1:101–111PubMedCrossRefGoogle Scholar
  4. Msall M, Batshaw ML, Suss R, Brusilow SWMelits ED, (1984) Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea cycle enzymopathies. N Engl J Med 310:1500–1505PubMedCrossRefGoogle Scholar
  5. Summar ML (1998) Molecular genetic research into carbamoyl-phosphate synthase I: Molecular defect and linkage markers. J Inher Metab Dis 21/1: 30–39PubMedCrossRefGoogle Scholar
  6. Tuchman M, Morizono H, Rajagopal BS, Plante RJ, Allewel NM (1998) The biochemical and molecular spectrum of ornithine transcarbamylase deficiency. J Inher Metab Dis 21/1:40–58PubMedCrossRefGoogle Scholar
  7. Uchino T, Endo F, Matsuda I (1998) Neurodevelopmental outcome of longterm therapy of urea cycle disorders in Japan. J Inher Metab Dis 21/1: 151–159PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • C. Bachmann

There are no affiliations available

Personalised recommendations